ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 125 filers reported holding ACORDA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $42,000 | -54.3% | 60,939 | -66.0% | 0.00% | -100.0% |
Q3 2020 | $92,000 | -5.2% | 179,426 | +35.6% | 0.00% | -50.0% |
Q2 2020 | $97,000 | +31.1% | 132,272 | +262.3% | 0.00% | – |
Q4 2019 | $74,000 | -97.4% | 36,510 | -82.8% | 0.00% | -100.0% |
Q1 2019 | $2,814,000 | +62.3% | 211,765 | +90.2% | 0.03% | +50.0% |
Q4 2018 | $1,734,000 | -30.3% | 111,325 | -12.1% | 0.02% | -33.3% |
Q3 2018 | $2,488,000 | +647.1% | 126,597 | +991.4% | 0.03% | +650.0% |
Q2 2018 | $333,000 | -38.0% | 11,600 | -49.0% | 0.00% | -55.6% |
Q1 2018 | $537,000 | -30.6% | 22,726 | -38.4% | 0.01% | -57.1% |
Q1 2017 | $774,000 | +7.9% | 36,880 | -3.3% | 0.02% | -27.6% |
Q4 2016 | $717,000 | – | 38,136 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |